Schrödinger, Inc. (NASDAQ:SDGR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine analysts that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $40.89.
Several equities research analysts have recently commented on the company. Piper Sandler lowered their target price on Schrödinger from $60.00 to $50.00 and set an “overweight” rating for the company in a research note on Thursday, February 29th. Bank of America decreased their price objective on Schrödinger from $38.00 to $32.00 and set a “neutral” rating for the company in a report on Thursday, February 29th. Citigroup reduced their target price on shares of Schrödinger from $39.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Craig Hallum dropped their price objective on Schrödinger from $35.00 to $30.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Finally, The Goldman Sachs Group reduced their target price on Schrödinger from $29.00 to $26.00 and set a “neutral” rating on the stock in a report on Friday, March 1st.
Get Our Latest Research Report on SDGR
Institutional Trading of Schrödinger
Schrödinger Stock Up 3.4 %
Shares of NASDAQ SDGR opened at $19.41 on Tuesday. Schrödinger has a 12 month low of $18.60 and a 12 month high of $59.24. The company has a market cap of $1.41 billion, a price-to-earnings ratio of -10.32 and a beta of 1.53. The business has a fifty day simple moving average of $22.50 and a 200-day simple moving average of $26.77.
Schrödinger (NASDAQ:SDGR – Get Free Report) last posted its earnings results on Wednesday, May 1st. The company reported ($0.76) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.76). Schrödinger had a negative net margin of 75.94% and a negative return on equity of 29.25%. The firm had revenue of $36.60 million during the quarter, compared to analysts’ expectations of $41.23 million. As a group, sell-side analysts expect that Schrödinger will post -2.7 EPS for the current fiscal year.
About Schrödinger
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Read More
- Five stocks we like better than Schrödinger
- Insider Buying Explained: What Investors Need to Know
- The Top 3 Sectors Poised For Growth This Summer
- Learn Technical Analysis Skills to Master the Stock Market
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- Why Invest in 5G? How to Invest in 5G Stocks
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.